VIVENDY THERAPEUTICS
Vivendy Therapeutics Ltd. has developed a specific recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) that is specifically modified to improve enzyme activity - enhancing the efficacy of the therapy in MPS IVA significantly
VIVENDY THERAPEUTICS
Industry:
Biotechnology Health Diagnostics Therapeutics
Founded:
2006-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.vivendy.ch
Total Employee:
11+
Status:
Closed
Contact:
41 61 271 87 80
Email Addresses:
[email protected]
Total Funding:
45.93 M USD
Technology used in webpage:
Domain Not Resolving
Current Employees Featured
Investors List
Aescap Venture
Aescap Venture investment in Series B - Vivendy Therapeutics
TVM Capital
TVM Capital investment in Series B - Vivendy Therapeutics
EQT Life Sciences
EQT Life Sciences investment in Series A - Vivendy Therapeutics
BioMedPartners
BioMedPartners investment in Series A - Vivendy Therapeutics
TVM Capital
TVM Capital investment in Series A - Vivendy Therapeutics
More informations about "Vivendy Therapeutics"
Vivendy Therapeutics - Crunchbase Company Profile & Funding
Vivendy Therapeutics is engaged in the development of enzyme replacement therapy. Vivendy Therapeutics Ltd. has developed a specific recombinant human N-acetylgalactosamine-6 …See details»
Vivendy Therapeutics | Company | RadialReport
Vivendy Therapeutics Ltd. engages in the development of an enzyme replacement therapy for Morbus Morquio, a rare lysosomal storage disease based on a gene deficiency. The company …See details»
Vivendy Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore Vivendy Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
vivendy.ch - Vivendy Therapeutics Ltd. - Vivendy - Sur.ly
Vivendy Therapeutics Ltd. Vivendy is a pharma development company located in Basel, SwitzerlandSee details»
Vivendy Therapeutics Ltd. - BioCentury Company Profiles - BCIQ
Enter a Company name above to access free BCIQ profiles. Historical deals and financings can be found by searching the organization's name in the BCIQ Deals and Financing Modules.See details»
Vivendy Therapeutics AG - life-sciences-europe.com
Upcoming Events. IMSC 2024 Melbourne; BIO-Europe 2024 Stockholm; J.P. Morgan 43rd Annual Healthcare Conference 2025 San Francisco; Enmore Bio China 2025 Suzhou (EBC 2025)See details»
Simplified organization chart and key figures - Vivendi
Vivendi considers these to be relevant indicators of the group’s operating and financial performance. Each of these indicators is defined in the appropriate section of this Financial Report or in its Appendix.See details»
Shareholders & investors in a nutshell - Vivendi
Vivendi’s Supervisory Board approves the resolutions regarding the Group’s spin-off to be submitted ... Dates given for information only and subject to change.See details»
The Annual Report – Universal Registration - Vivendi
CHAPTER 1 SECTION1.PROFILE OF THE GROUP 1.1.Creation, Production and Distribution Since 2014, Vivendi has been building a large European cultural group with international reach …See details»
www.vivendi.ch
Www.vivendi.chSee details»
Jörg Neermann - Crunchbase Person Profile
Jörg Neermann, PhD, joined LSP as a Partner in the Munich Office in early 2007 and serves as member of the supervisory board of Affimed Therapeutics (D), Vivendy (CH) and Curetis (D) and is an observer to the supervisory board of …See details»
Vivendi Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 · Vivendi has 5 employees across 2 locations and €10.51 b in annual revenue in FY 2023. See insights on Vivendi including office locations, competitors, revenue, financials, …See details»
Vivendi - Festival And International See Tickets Business
Sub-Organization of . Vivendi . Operating Status Active; Company Type For Profit; Vivendi - Festival And International See Tickets Business is a unit of Vivendi that offers full ticketing …See details»
The Group’s origins - Vivendi
Vivendi emerged from Compagnie Générale des Eaux (CGE), a company founded in the mid-19th century. Created by Imperial decree on December 14, 1853, CGE originally supplied water to …See details»
Vivendi is a global leader
Vivendi owns 10% of the UMG share capital following the distribution of 60% to its shareholders and UMG’s first trading day on the Euronext Amsterdam stock market on September 21, 2021See details»
Vivendi: new governance and creation of the Vivendi Foundation
Vivendi has decided to open a new chapter in its history today, following the distribution of 60% of the share capital of Universal Music Group and its listing on the Amsterdam stock exchange, …See details»
Vivendi – Aktuelle News und alle Informationen zum …
Der konservative Unternehmer Vincent Bolloré besitzt ein Firmenimperium. Sein Medienkonzern Vivendi erwägt nun aber die Abspaltung zweier wichtiger Sparten. Das Vorgehen könnte sich …See details»
New governance of Vivendi and Foundation
May 19, 2022 · Vivendi has decided to open a new chapter in its history today, following the distribution of 60% of the share capital of Universal Music Group and its listing on the …See details»
Vivendi: New Governance and Creation of the Vivendi Foundation
May 19, 2022 · Vivendi (Paris:VIV) has decided to open a new chapter in its history today, following the distribution of 60% of the share capital of Universal Music Group and its listing on …See details»
Vivendi completes its transaction with Lagardère
Nov 21, 2023 · Vivendi is pleased to announce the closing of its transaction with the Lagardère group. This operation gives it a whole new dimension by strengthening its position as a major …See details»